Eli Lilly and Company ( LLY) - Stock Earnings
LLY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 5.6 billion USD | 17.6 billion USD |
| 2025Q4 | 6.6 billion USD | 19.3 billion USD |
| 2026Q1 | 7.4 billion USD | 19.8 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
LLY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.2 billion USD | 34.1 billion USD |
| 2024 | 10.6 billion USD | 45.0 billion USD |
| 2025 | 20.6 billion USD | 65.2 billion USD |
| 2026 Est. | — | — |
LLY
List: Contenders
Price: $1,133
Dividend Yield: 0.61%
Forward Dividend Yield: 0.61%
Payout Ratio: 63.73%
Dividend Per Share: 6.92 USD
Earnings Per Share: 28.18 USD
P/E Ratio: 35.03
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 2.6 million
Ebitda: 758.9 millionMarket Capitalization: 1.1 trillion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 16.91%
DGR5: 16.13%
DGR10: 11.60%
DGR20: 7.34%